Zika virus-like particle (VLP) based vaccine

Structural Basis of Zika Virus-Specific Antibody Protection

(2016) Haiyan Zhao et al.   CELL

Viral load kinetics of Zika virus in plasma, urine and saliva in a couple returning from Martinique, French West Indies

(2016) Camille Fourcade et al.   JOURNAL OF CLINICAL VIROLOGY

Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study

(2016) Van-Mai Cao-Lormeau et al.   LANCET

Evidence of Sexual Transmission of Zika Virus

(2016) Eric D’Ortenzio et al.   NEW ENGLAND JOURNAL OF MEDICINE

Neutralizing antibody titers against dengue virus correlate with protection from symptomatic infection in a longitudinal cohort

(2016) Leah C. Katzelnick et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The 3.8 A resolution cryo-EM structure of Zika virus

(2016) D. Sirohi et al.   SCIENCE

Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus

(2016) J. A. Swanstrom et al.   mBio

Detection of Zika virus in saliva

(2015) Didier Musso et al.   JOURNAL OF CLINICAL VIROLOGY

First report of autochthonous transmission of Zika virus in Brazil

(2015) Camila Zanluca et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Recognition determinants of broadly neutralizing human antibodies against dengue viruses

(2015) Alexander Rouvinski et al.   NATURE

Long-Term Efficacy of a Hepatitis E Vaccine

(2015) Jun Zhang et al.   NEW ENGLAND JOURNAL OF MEDICINE

Generation and preclinical immunogenicity study of dengue type 2 virus-like particles derived from stably transfected mosquito cells

(2015) Amporn Suphatrakul et al.   VACCINE

A New Quaternary Structure Epitope on Dengue Virus Serotype 2 Is the Target of Durable Type-Specific Neutralizing Antibodies

(2015) E. N. Gallichotte et al.   mBio

A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins

(2015) Guntur Fibriansah et al.   Nature Communications

Molecular Evolution of Zika Virus during Its Emergence in the 20th Century

(2014) Oumar Faye et al.   PLoS Neglected Tropical Diseases

Optimization and Validation of a Plaque Reduction Neutralization Test for the Detection of Neutralizing Antibodies to Four Serotypes of Dengue Virus Used in Support of Dengue Vaccine Development

(2013) Tatyana M. Timiryasova et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

The history of MF59®adjuvant: a phoenix that arose from the ashes

(2012) Derek T O’Hagan et al.   Expert Review of Vaccines

Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions

(2012) R. de Alwis et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Genetic Characterization of Zika Virus Strains: Geographic Expansion of the Asian Lineage

(2012) Andrew D. Haddow et al.   PLoS Neglected Tropical Diseases

MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines

(2011) S. Khurana et al.   Science Translational Medicine

Zika Virus Outbreak on Yap Island, Federated States of Micronesia

(2009) Mark R. Duffy et al.   NEW ENGLAND JOURNAL OF MEDICINE